Literature DB >> 3356969

Characterization of an immunodominant Onchocerca volvulus antigen with patient sera and a monoclonal antibody.

R Lucius1, H Schulz-Key, D W Büttner, A Kern, B Kaltmann, J Prod'hon, F Seeber, R D Walter, K C Saxena, H J Diesfeld.   

Abstract

Adult Onchocerca voluvlus and infective larvae, but not microfilariae contain an immunodominant antigen (33,000 and 21,000 Mr in females, 39,000, 33,000, and 21,000 Mr in males, 133,000 Mr in infective larvae) which is recognized by an Onchocerca-specific mAb. The component is part of the reproductive organs and muscles. 96.2% of onchocerciasis sera contained antibodies detectable by immunoblotting against it. Antigen purified by immunoaffinity chromatography was specifically recognized in immunoblots by onchocerciasis sera, but not by sera from other filarial infections. The high immunogenicity, the specificity, and the occurrence in infective larvae of this antigen indicate an immunodiagnostic potential and a possible role in the immunobiology of the parasite.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3356969      PMCID: PMC2188921          DOI: 10.1084/jem.167.4.1505

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Antibody responses in forest and savanna onchocerciasis in Ivory Coast.

Authors:  R Lucius; J Prod'Hon; A Kern; G Hébrard; H J Diesfeld
Journal:  Trop Med Parasitol       Date:  1987-09

2.  Identification of paramyosin as schistosome antigen recognized by intradermally vaccinated mice.

Authors:  D E Lanar; E J Pearce; S L James; A Sher
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

3.  Isolation of living adult Onchocerca volvulus from nodules.

Authors:  H Schulz-Key; E J Albiez; D W Büttner
Journal:  Tropenmed Parasitol       Date:  1977-12

4.  Identification of antigens of Onchocerca volvulus and Onchocerca gibsoni for diagnostic use.

Authors:  Z Cabrera; R M Parkhouse
Journal:  Mol Biochem Parasitol       Date:  1986-09       Impact factor: 1.759

Review 5.  Onchocerciasis.

Authors:  B O Duke
Journal:  Br Med Bull       Date:  1972-01       Impact factor: 4.291

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

8.  Preparation of monoclonal antibodies: strategies and procedures.

Authors:  G Galfrè; C Milstein
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

9.  Identification of non-cross-reacting antigens of Onchocerca volvulus with lymphatic filariasis serum pools.

Authors:  E Lobos; N Weiss
Journal:  Parasitology       Date:  1986-10       Impact factor: 3.234

10.  A study on antigen recognition by onchocerciasis patients with different clinical forms of disease.

Authors:  R Lucius; D W Büttner; C Kirsten; H J Diesfeld
Journal:  Parasitology       Date:  1986-06       Impact factor: 3.234

View more
  3 in total

Review 1.  [Molecular biological techniques in the diagnosis of tropical parasitic diseases].

Authors:  R Felleisen; M Q Klinkert
Journal:  Naturwissenschaften       Date:  1992-11

2.  Serological cross-reactivity between a human Ro/SS-A autoantigen (calreticulin) and the lambda Ral-1 antigen of Onchocerca volvulus.

Authors:  F A Lux; D P McCauliffe; D W Büttner; R Lucius; J D Capra; R D Sontheimer; T S Lieu
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

3.  An aspartyl protease inhibitor orthologue expressed by Parelaphostrongylus tenuis is immunogenic in an atypical host.

Authors:  Michael S Duffy; Nancy MacAfee; Michael D B Burt; Judith A Appleton
Journal:  Clin Diagn Lab Immunol       Date:  2002-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.